جستجوی استاد راهنمای دانشگاهی

Joseph P. Bressler is an Associate Professor at Johns Hopkins University, jointly affiliated with the Bloomberg School of Public Health and the Krieger School of Arts and Sciences. He is a member of the Department of Environmental Health and Engineering and conducts research at the Kennedy Krieger Institute in Baltimore, Maryland. His work bridges public health, neuroscience, and molecular toxicology, focusing on environmental impacts on brain development. Education: PhD, Rutgers University, 1978 Dr. Bressler’s research centers on neurotoxicology, particularly how environmental pollutants such as lead, cadmium, and aluminum disrupt metal transport systems and affect neurodevelopment. His laboratory investigates the role of iron and other metal transporters at the blood-brain barrier and in glial cells, revealing mechanisms of metal uptake and toxicity. His work has implications for understanding autism, fetal alcohol syndrome, and other neurodevelopmental disorders. His recent publications highlight ongoing research into metal homeostasis, cytotoxicity in cancer and neuronal cell lines, e-cigarette aerosol variability, and epigenetic changes in sex chromosome aneuploidies. The research spans molecular mechanisms, in vitro models, and human health outcomes, demonstrating a multidisciplinary approach to environmental health. Scientific Contributions: Elucidated how lead and cadmium hijack iron transporters to enter the brain Demonstrated aluminum activation of iron uptake pathways in glial cells Investigated flavoring agents like ethyl maltol in enhancing metal toxicity Explored epigenetic and behavioral impacts in rare genetic conditions Dr. Bressler has advised numerous researchers and collaborators across disciplines. His work has been supported by federal and institutional grants, though specific funding details are not provided in the source text. He actively publishes in high-impact toxicology and environmental health journals, with research cited in policy and public health discussions. He leads a research laboratory focused on cellular and molecular mechanisms of neurotoxicity, utilizing in vitro models of the blood-brain barrier, astrocytes, and neuronal cell lines. His team collaborates widely across neuroscience, public health, and environmental engineering domains.

• Neurotoxicology
• Environmental Health Sciences
• Metal Transporters
• +۱۲ مورد دیگر

Christopher J. Chang is the Edward and Virginia Taylor Professor of Bioorganic Chemistry at Princeton University's Department of Chemistry. His research focuses on chemical biology, catalysis, and inorganic chemistry, with an emphasis on transition metal signaling, activity-based sensing, and drug discovery. He leads the Chang Lab, which develops innovative chemical tools to study metal-dependent biological processes, including copper's role in neurobiology and cancer, formaldehyde's role in epigenetic regulation, and redox-driven protein function. His work integrates organic, inorganic, and biological chemistry, enabling discoveries in imaging, proteomics, and precision medicine. Notable achievements include pioneering activity-based sensing platforms for copper and reactive metabolites, revealing metalloplasia in cancer, and developing copper-specific therapies. Christopher Chang has received over 50 prestigious awards, including the Guggenheim Fellowship and the Howard Hughes Medical Institute Investigatorship. His lab's infrastructure includes advanced analytical instruments, synthetic chemistry facilities, and cell culture capabilities, supported by grants from NIH, NSF, and industry partnerships. Awards: ACS Bader Award (2024), Ivano Bertini Award (2022), Blavatnik National Award (2015) Lab Focus Areas: Transition metal signaling, copper-dependent biology, formaldehyde metabolism, redox drug discovery Key Technologies: Activity-based sensors, imaging probes, bioconjugation methods

• Chemical Biology
• Catalysis/Synthesis
• Inorganic Chemistry
• +۵ مورد دیگر

Katherine J. Franz is a Professor of Chemistry at Duke University, affiliated with the Trinity College of Arts & Sciences and the Duke Cancer Institute. She holds a Ph.D. from MIT (2000) and a B.A. from Wellesley College (1995). Her research focuses on bioinorganic chemistry, particularly metal ion coordination in biological systems, with applications in antimicrobial therapies, cancer metallomics, and neurodegenerative diseases. Key projects include developing prochelators targeting fungal and bacterial pathogens, studying copper's role in antifungal drug efficacy, and designing light-activated metal complexes for controlled drug release. Dr. Franz has received numerous awards including the Camille Dreyfus Teacher-Scholar Award (2009), Sloan Research Fellowship (2008), and the NSF CAREER Award (2005). She leads a lab with 6 current students/mentees and has secured grants from NIH, NSF, and the US-Israel Binational Science Foundation. Her lab's work spans from fundamental metalloprotein studies to translational drug development, emphasizing interdisciplinary approaches in chemistry and biology. Education: Ph.D. in Chemistry, MIT, 2000 B.A. in Chemistry, Wellesley College, 1995 Research Interests: Metal homeostasis in pathogens, copper's role in antifungal resistance, prodrug design for targeted therapy, and mechanistic studies of metalloproteins. Grants: Tri-Institutional Molecular Mycology Training Program (NIH, 2024–2029) Duke PREP Biomedical Sciences Program (NIGMS, 2022–2027) Copper-Mucin Interaction Study (BSF, 2022–2026) Her lab's publications (n=15+ since 2020) highlight breakthroughs in prodrug selectivity, copper-induced protein toxicity, and histatin antifungal mechanisms. The Franz Lab actively collaborates with clinicians and computational scientists to advance therapeutic strategies addressing unmet medical needs in infectious diseases and cancer.

• Bioinorganic Chemistry
• Metal Homeostasis
• Antimicrobial Agents
• +۴ مورد دیگر

Michael Krisinger is an Associate Professor of Teaching in the Department of Biochemistry & Molecular Biology at the University of British Columbia . He began his teaching career in 2010, transitioning to full-time in 2013. He lectures Biochemistry 202 (Introductory Medical Biochemistry) and Biochemistry 303 (Molecular Biochemistry) while serving as a tutor in the Faculty of Medicine's Case Based Learning program. Krisinger co-developed the department's two-course summer program for international students and mentors postdoctoral fellows in teaching. He also manages the department's CANVAS digital learning platform. Krisinger's research focuses on the molecular mechanisms of coagulation and complement system regulation , particularly their evolutionary relationship and functional interplay. His work has explored thrombin's role in complement activation, polyphosphate-mediated complement suppression, and nanoparticle surface interactions with proteolytic cascades. He previously co-supervised graduate students at UBC's Centre for Blood Research before prioritizing education. Publications highlight his expertise in protease-substrate dynamics , lipoprotein-phospholipid interactions , and hemostasis-immunity crosstalk . He remains engaged in public science through community environmental initiatives and local outreach activities.

• Biochemistry
• Molecular Biology
• Coagulation
• +۳ مورد دیگر

Guojun Chen is an Assistant Professor at the Department of Biomedical Engineering and a member of the Rosalind & Morris Goodman Cancer Institute (GCI) at McGill University . His research focuses on engineering intelligent biomaterials for precision medicine , with emphasis on non-viral genome editing , cold atmospheric plasma (CAP) therapy , and biomaterials-mediated immunotherapy . The lab operates in a multidisciplinary environment , integrating principles from materials science , chemistry , biology , and health sciences . Education : Ph.D. from University of Wisconsin-Madison (2017), Postdoc at UCLA (2020) Research Themes : Genome Editing Delivery : Designing non-viral vectors for efficient CRISPR/Cas9 delivery in vivo. CAP-mediated Immunotherapy : Developing portable cold plasma devices to synergize with immune checkpoint blockade and study CAP’s immunological mechanisms. Biomaterials-based Immunotherapy : Reprogramming tumor microenvironments using bioresponsive materials to enhance immune responses. Publication Trends : Recent work spans responsive nanomaterials , genomic editing systems , and plasma oncology , with a focus on cancer immunotherapy , diabetes diagnostics , and bioinspired medical devices . Scientific Awards : Canada Research Chair (2024, 2025) McGill's President's Prize for Emerging Researchers (2025) FRQS Chercheurs-boursiers (2022) Chinese Association for Biomaterials Young Investigator Award (2022) NSERC Discovery Grant (2021) Advising & Grants : Supervises 14 current graduate and undergraduate students. Secured $5M+ in funding from CIHR , NSERC , CCS , and CFI , including multi-institutional collaborations with Dr. Morag Park , Dr. Réjean Lapointe , and Dr. Ian Watson .

• Biomaterials
• Nanomedicine
• Tissue Engineering
• +۵ مورد دیگر

Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.

• Virology
• Molecular Pathology
• Host-Pathogen Interactions
• +۵ مورد دیگر

Daniela Strenkert is an Assistant Professor at Michigan State University, affiliated with the MSU-DOE Plant Research Laboratory, Plant Biology Department, Molecular Plant Sciences Program, BioMolecular Science Gateway, and Cell & Molecular Biology Program. Her research focuses on systems biology approaches to understand gene regulation in photosynthetic organisms. Ph.D., University of Kaiserslautern, Germany Her lab investigates photosynthetic performance through multi-omics analysis of chromatin structure, transcriptomes, proteomes, and metabolomes in Chlamydomonas reinhardtii . Key areas include environmental acclimation, histone modification mapping (GreENCODE project), and regulatory RNA characterization. Recent publications emphasize computational modeling of photosynthetic protein interactions, metal homeostasis under stress, and chloroplast protein import mechanisms. Articles span 2025-2010, with 15 most recent from 2025-2022. Her work integrates genome-wide datasets to decode algal regulatory programs under climate change-relevant stressors. She teaches BS 161: Cells and Molecules and maintains a lab at 106 Plant Biology Lab. Contact: strenke2@msu.edu .

• Plant Biology
• Systems Biology
• Molecular Biology
• +۱۲ مورد دیگر

Tohru Fukai is a Professor and holds the Barbara A. Schnuck Endowed Chair in Translational Medicine at the Medical College of Georgia, Augusta University, where he serves in the Department of Pharmacology and Toxicology. His research is centered at the Vascular Biology Center, where he leads a productive laboratory investigating the molecular mechanisms of oxidative stress and dysfunctional copper metabolism in cardiovascular and metabolic diseases. Dr. Fukai earned his MD in 1988 and PhD in Medical Science in 1995, both from Kyushu University in Japan. Following his medical and doctoral training, he completed postdoctoral fellowship at Emory University School of Medicine in Atlanta from 1995-1999. His research focuses on oxidative stress in cardiovascular and metabolic disease pathogenesis, particularly investigating the role of extracellular SOD (ecSOD, SOD3) and copper transport proteins. His lab has pioneered research on copper transport proteins CTR1, Atox1, and ATP7A in regulating vascular function, demonstrating their critical roles in hypertension, vascular remodeling, inflammatory angiogenesis, atherosclerosis, and diabetes. Notably, his team discovered that copper chaperone Atox1 functions as a copper-dependent transcription factor regulating cell proliferation and inflammatory responses. Analysis of Dr. Fukai's recent publications reveals a strong focus on the intersection of redox signaling, copper metabolism, and vascular function. His work increasingly explores how oxidative stress and copper transport mechanisms contribute to conditions like diabetes, atherosclerosis, Alzheimer's disease, and ischemic injury. A prominent theme across his recent work is the role of protein modifications (particularly sulfenylation and SUMOylation) in regulating vascular responses to oxidative stress, with significant implications for therapeutic interventions. Dr. Fukai's scientific achievements have been recognized with numerous awards including the Barbara A. Schnuck Endowed Chair in Translational Medicine (2017), World Science Leaders in Human Biology Program (2021), and multiple Circulation Research Reviewer Awards. He has served on editorial boards for prestigious journals including Scientific Reports, Journal of Molecular and Cellular Cardiology, and American Journal of Physiology-Heart and Circulatory Physiology. As a mentor, Dr. Fukai has advised numerous graduate students and postdoctoral fellows, including several who have received AHA awards and trainee recognition. He serves on various committees including the VBC post-doc evaluation committee and the CNVAMC Subcommittee for Research Safety. His lab has secured significant funding, including a recent $11.3 million NIH grant for vascular disease research. Dr. Fukai leads an active research group at the Vascular Biology Center comprising senior research associates, assistant research scientists, postdoctoral fellows, and graduate students working collaboratively on multiple projects related to copper transport, redox signaling, and vascular disease mechanisms. His lab has made seminal contributions to understanding how copper transport proteins function as key regulators of vascular antioxidant enzymes and as unexpected signaling molecules in inflammatory disease processes.

• Oxidative stress
• Cardiovascular disease
• Metabolic disease
• +۷ مورد دیگر

Derek S. Tan is a Professor in the Department of Biochemistry and Biophysics at Weill Cornell Medical College, holding a Tri-Institutional Professor position effective from 2025. His research integrates chemical synthesis with biological applications, focusing on drug discovery, enzyme mechanisms, and therapeutic engineering. He maintains an active research program with continuous NIH funding. Education: Ph.D., Harvard University (2000) B.S., Stanford University (1995) Research Focus: Professor Tan's work spans chemical biology, medicinal chemistry, and microbiology. He designs bioactive molecules targeting bacterial permeability, enzyme inhibition, and cellular therapeutics. Key areas include ubiquitin pathway biochemistry, antibiotic development against Mycobacterium tuberculosis and Plasmodium falciparum , and engineered T-cell therapies for cancer. His interdisciplinary approach bridges synthetic chemistry with translational applications. Publication Trends: Recent articles (2021-2024) demonstrate three primary themes: 1) Development of mechanistic probes for enzyme systems (ubiquitin pathway, aminoacyl-tRNA synthetases), 2) Antibacterial/antiparasitic agent design leveraging bacterial permeability studies, and 3) Cellular engineering strategies including CAR-T micropharmacies for targeted drug activation. The work consistently combines synthetic chemistry innovation with biological validation. Grants: As Principal Investigator of the Tri-institutional PhD Program in Chemical Biology (NIH/NIGMS funded), he leads initiatives spanning 2020-2025 and 2025-2030. This underscores sustained commitment to interdisciplinary training at the chemistry-biology interface.

• Chemical Biology
• Medicinal Chemistry
• Biochemistry
• +۳ مورد دیگر

Xi-Long Zheng is a tenured Professor in the Department of Biochemistry and Molecular Biology and Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He holds additional appointments as a Member of the Libin Cardiovascular Institute and Associate Member of both the Snyder Institute for Chronic Diseases and Arnie Charbonneau Cancer Institute. His research focuses on vascular smooth muscle biology and its role in cardiovascular diseases. Doctor of Medicine, Hunan Medical University (1986) M.S. in Pharmacology, Hunan Medical University (1989) Doctor of Philosophy in Pharmacology, University of Calgary (1997) Dr. Zheng's research centers on vascular smooth muscle cell differentiation, proliferation, and phenotypic switching in vascular diseases. His laboratory investigates mechanisms of vascular smooth muscle dedifferentiation in atherosclerosis, abdominal aortic aneurysms, and vascular stiffness. Current work explores ferroptosis, epigenetic regulation (particularly BRD4), and PCSK9 functions in vascular pathologies. His studies integrate molecular, cellular, and in vivo approaches to identify novel therapeutic targets for cardiovascular diseases. Analysis of his recent publications reveals strong emphasis on cell death mechanisms (ferroptosis, cuproptosis), epigenetic regulation, lipid metabolism, and immune-vascular interactions in atherosclerosis. His work demonstrates increasing focus on translational applications targeting vascular smooth muscle phenotypic switching and plaque stability. Alberta Innovates ‒ Health Solutions Senior Scholar Award (2008-2015) Heart & Stroke Foundation New Investigator Award (2001-2006) CIHR/Hypertension Society Scholarship Award (2001-2004) Heart & Stroke Foundation Fellowship Award (1999-2001) AHFMR Independent Investigator Award (2008) Dr. Zheng serves on grant panels for Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada. He is an editorial board member for Biochemical Journal and other scholarly publications. His laboratory receives funding from CIHR and NSERC for projects including smooth muscle PCSK9 in abdominal aortic aneurysm pathogenesis, smooth muscle autophagy in vascular aging, and epigenetic regulation of smooth muscle plasticity. The Zheng Lab investigates vascular smooth muscle functions across multiple organ systems including blood vessels, gastrointestinal tract, bladder, and uterus. His research has established critical mechanisms in vascular smooth muscle differentiation and cell cycle regulation, contributing over 100 peer-reviewed publications in high-impact journals including PNAS, ATVB, Diabetologia, JBC, and Hypertension.

• Vascular Smooth Muscle Biology
• Atherosclerosis
• Vascular Disease Mechanisms
• +۴ مورد دیگر

Namrata Singh, Ph.D. (Indian Institute of Science), is an Assistant Professor in the Department of Chemistry at Indian Institute of Technology Kanpur. Her research integrates material chemistry and biology to develop therapeutic nanomaterials for high-mortality diseases and resilient infections, alongside innovative diagnostic tools. Education and Training: Ph.D. in Chemistry, Indian Institute of Science Postdoctoral Fellow, Karolinska Institute, Stockholm (2022-2023) Postdoctoral Fellow, Imperial College London (2020-2022) Scientist, CSIR-Central Drug Research Institute, Lucknow (2023-2024) Research Interests: Dr. Singh’s laboratory focuses on therapeutic nanomaterials targeting drug-resistant bacterial infections and precise cancer therapy . Her group designs bioinspired, stimuli-responsive nanomaterials that act as antibiotic carriers and standalone bactericidal agents against biofilms and multidrug-resistant pathogens. In oncology, she develops nanomedicines that modulate the tumor microenvironment and control programmed cell death pathways (ferroptosis, apoptosis) to enhance therapeutic selectivity and minimize off-target toxicity. Scientific Awards & Fellowships: Karolinska Institute Research Foundation Grant (2023) MSCA Vinnova Postdoctoral Fellowship, Swedish Innovation Agency (2022) IUPAC-Solvay International Award for Young Chemists (2020) Alexander von Humboldt & ETH Zürich Postdoctoral Fellowships (2020, not availed) Metrohm Young Chemist Award (2019) Indian Academy of Sciences Summer Research Fellowship (2011) Contact: Office FB 437, Faculty Building, Department of Chemistry, IIT Kanpur, Kanpur 208016 Phone: +91-512-259-2527 | Email: namrata@iitk.ac.in

• Chemical Biology
• Bioinorganic Chemistry
• Nanomaterials for Biomedical Applications
• +۳ مورد دیگر

Christoph J. Fahrni is a Professor at the School of Chemistry and Biochemistry, Georgia Institute of Technology. He earned his M.S. from the Federal Institute of Technology (ETH) in Zurich and a Ph.D. in Chemistry from the University of Basel in 1995. After postdoctoral work at Northwestern University, he joined Georgia Tech in 1999, where his research focuses on metal ion biochemistry, particularly copper and zinc, using fluorescent probes and X-ray fluorescence imaging. Education: M.S., Federal Institute of Technology (ETH), Zurich Ph.D., University of Basel, 1995 His research integrates synthetic fluorescent probes and X-ray fluorescence microscopy to study intracellular metal ion dynamics, including copper trafficking, zinc homeostasis, and their roles in diseases like Menkes syndrome. The lab develops high-affinity ligands for copper buffering, investigates P-type ATPase transporters, and uses 3D X-ray tomography to map metals in zebrafish embryos. Key methodologies include ratiometric two-photon microscopy and bioorganometallic catalyst design. Recent publications highlight advancements in subzeptomolar copper probes, dynamic zinc imaging during development, and metal chelation therapy applications. Collaborative projects with Prof. Robert Dickson explore low-background fluorescent protein imaging. The Fahrni group trains graduate students like Daisy Bourassa and Adam McCallum, focusing on biochemical copper/zinc interactions and probe development.

• Bioinorganic Chemistry
• Fluorescent Probes
• Metal Ion Homeostasis
• +۴ مورد دیگر

Dr Ruan Elliott is Dean of the Doctoral College and Senior Lecturer in Nutrition at the University of Surrey's School of Biosciences. He holds a PhD in Nutritional Metabolism (2017) and BA in Natural Sciences from Cambridge (1988). His research focuses on nutritional modulation of DNA repair mechanisms, functional genomics in nutrigenomics, and micronutrient homeostasis of iron, copper, selenium, and zinc. He has led studies on vitamin D efficacy, food bioavailability, and oxidative stress biomarkers. Education: PhD (University of Surrey, 1992), BA (University of Cambridge, 1988) Previous Roles: Senior Scientist (Institute of Food Research, 1994-2009), Postdoctoral Fellow (University of British Columbia, 1992-1994) His research integrates molecular biology and nutrition to address health impacts of dietary components. Recent work explores oat-based milk alternatives' sensory profiles, vitamin D supplementation efficacy, and DNA repair pathways in cardiovascular disease. He collaborates internationally on projects like the D2-D3 Study and NuGO initiatives. Publications emphasize translational research, including systematic reviews on insect protein efficacy and meta-analyses of vitamin D supplementation. His work bridges lab-based models (e.g., Caco-2 cells for iron studies) and clinical applications. No scientific awards were explicitly listed in the provided texts. He advises on doctoral training programs and has contributed to grant-funded projects like the University of Surrey's food and infection biosciences initiative (2024). Collaborations include studies on probiotics' immune effects and transcriptomic analysis of metabolic conditions.

• Nutritional Metabolism
• DNA Damage and Repair
• Nutrigenomics
• +۴ مورد دیگر

Joseph Cotruvo is a Professor of Chemistry at the Department of Chemistry, Pennsylvania State University. His research focuses on understanding metal selectivity in biological systems, particularly lanthanides and transition metals, with applications in biotechnology, environmental science, and disease mechanisms. He leads the Cotruvo Lab, which develops biochemical and chemical biology tools to study metal ion acquisition, trafficking, and utilization in bacteria and human pathogens. Education: Ph.D., Chemistry, Massachusetts Institute of Technology (2012); A.B., Chemistry, Princeton University (2006). Research interests include lanthanide-dependent enzymology, protein engineering for rare earth element separations, and transition metal roles in neurodegenerative diseases. The lab designs fluorescent sensors, genetically encodable tools, and protein-based systems for metal detection and recovery. Recent work emphasizes actinide/lanthanide speciation, biohydrometallurgy, and biomolecular mechanisms of metal ion transport. Notable achievements include the discovery of lanmodulin—a highly selective lanthanide-binding protein—and its application in rare earth element recovery. His lab pioneered protein-based approaches for high-purity rare earth separations and developed manganese(II) fluorescent sensors. Research also explores iron-responsive riboswitches and copper-regulated lipid metabolism. Awards: Faculty Scholar Medal (2025), Blavatnik Finalist (2024), Eli Lilly Award (2024), Sloan Fellowship (2021), DOE Early Career Award (2020). Grants: NSF CAREER Award, Charles E. Kaufman Foundation, Jane Coffin Childs Memorial Fund. Labs/Teams: Cotruvo Lab (Penn State); collaborations with National Synchrotron Light Source, Lawrence Livermore National Laboratory. Future work targets scalable rare earth recovery systems, actinide-biomolecule interactions, and transition metal roles in infectious diseases.

• Biochemistry
• Biophysics
• Catalysis
• +۹ مورد دیگر

Gema Barrientos Vicho is an Adjunct Professor at the Faculty of Education, Universidad de Extremadura, specializing in Physical Education and Sport. She is affiliated with the HEART Health, exercise physiology and training research group and previously worked with GIADES (Investigación en actividad física, deporte y salud), a consolidated research unit of Castilla y León. Education: PhD in Physical Education and Sport Sciences from Universidad de Extremadura (2012), with a thesis on physiological changes in endurance athletes during competitive seasons. Research Focus: Her work explores trace mineral dynamics, hormonal adaptations, and oxidative stress in endurance athletes. Key areas include erythrocyte fatty acid profiles, metal excretion patterns during training, and nutritional biochemistry related to performance. Publication Trends: Recent articles analyze seasonal physiological adaptations, acute exercise effects on antioxidant systems, and longitudinal impacts of training on trace metal concentrations. These studies bridge sports nutrition, exercise physiology, and metabolic regulation. Contact: Email: gbarrientosvi@upsa.es

• Exercise Physiology
• Sports Training
• Trace Minerals in Sports
• +۳ مورد دیگر